Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands.
D000818:Animals; D045744:Cell Line, Tumor; D054357:Chemokine CXCL10 / Q000502:physiology*; D007167:Immunotherapy; D007371:Interferon-gamma / Q000502:physiology*; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000502:physiology*; D016399:Lymphoma, T-Cell / Q000276:immunology / Q000401:mortality / Q000628:therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000628:therapy; D054367:Receptors, CXCR3 / Q000502:physiology*; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7 / Q000032:analysis
D054357:Chemokine CXCL10; C485433:Cxcl10 protein, mouse; C515188:Cxcr3 protein, mouse; D007376:Interleukin-2; D054367:Receptors, CXCR3; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7; D007371:Interferon-gamma